pharmaphorum February 19, 2024
As all eyes are on a landmark Supreme Court hearing on how patients in the US can access abortion pill mifepristone next month, a study has found that it is safe and effective when prescribed and delivered using telemedicine.
The new analysis, published in the journal Nature Medicine, shows that women who received pharmacological abortion using mifepristone and misoprostol after an online consultation and delivery through the mail had similar outcomes to those prescribed it after an in-clinic visit.
On 26th March, SCOTUS is scheduled to hear a case brought by the conservative group Alliance for Hippocratic Medicine (AHM) challenging policies adopted by the FDA to expand access to the mifepristone/misoprostol regimen used for abortion, allowing remote consultations and self-reported...
Today's Sponsors
Today's Sponsor